No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 7.0x · 10Y median 9.5x · 26th percentile · as of Sep 10, 2026
Annualized revenue (TTM) · by quarter, last 26
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-11T02:29:51.667Z. Latest historical point 2026-09-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for C3.ai, Inc. (AI) stock was $10.47 as of Sep 10, 2026, 4:00 PM EDT, up 0.87% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -33.0% · 3-year avg -27.9%/yr · 5-year avg -26.9%/yr
C3.ai, Inc. is a leading provider of enterprise artificial intelligence (AI) software solutions, serving a global clientele across North America, Europe, the Middle East, Africa, and the Asia Pacific region.
Software - Application · Redwood City, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-04-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2024-04-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Dec 2, 2026
82 days away
EPS Estimate
-0.22
Revenue Est.
$53.39M
Last Quarter Results
EPS
$-0.20
vs Estimate
$-0.26
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AI | $1.59B | $10.47 | +0.87% | -32.95% | -26.86% | N/A | N/A |
| 2QUBT | $1.76B | $7.82 | -2.74% | -50.39% | +3.26% | +44.69% | vs AI |
| 3PD | $1.25B | $13.75 | +1.25% | -13.75% | -20.78% | N/A | vs AI |
| 4ICHR | $1.94B | $55.77 | -3.65% | +237.67% | +4.89% | N/A | vs AI |
| 5SHAZ | $1.98B | $56.57 | -0.32% | N/A | N/A | N/A | vs AI |
| 6ASAN | $2.03B | $8.56 | +3.76% | -35.56% | -38.54% | N/A | vs AI |
N/A
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$52.38M
vs Estimate
$52.06M
Consensus Rating
Based on 11 analysts
Average Price Target
$8.82
-15.8% downside
Low
$6.00
Current
$10.47
High
$15.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Jul 2026 | $-0.28 | $-0.26 | $-0.24 | 10 |
| Quarter ending Oct 2026 | $-0.25 | $-0.21 | $-0.17 | 10 |
| Quarter ending Jan 2027 | $-0.20 | $-0.18 | $-0.16 | 9 |
| Quarter ending Apr 2027 | $-0.17 | $-0.16 | $-0.15 | 7 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $-0.81 | $-0.76 | $-0.67 | 9 |
| FY 2028 | $-0.58 | $-0.48 | $-0.31 | 7 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Jul 2026 | $51.09M | $52.06M | $52.75M | 10 |
| Quarter ending Oct 2026 | $52.57M | $53.39M | $54.22M | 8 |
| Quarter ending Jan 2027 | $53.40M | $56.99M | $59.36M | 10 |
| Quarter ending Apr 2027 | $56.73M | $59.14M | $61.49M | 9 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $213.16M | $222.20M | $224.62M | 11 |
| FY 2028 | $234.03M | $245.14M | $257.41M | 10 |
